As it advances a monoclonal antibody targeting Guillain-Barré syndrome (GBS), Annexon Biosciences is embarking on another ...

Annexon, Inc. (NASDAQ:ANNX) on Tuesday presented data for its late-stage targeted therapy, tanruprubart (formerly ANX005), ...

Ironwood saw its share prices drop for a fifth straight day on Wednesday, losing 7.21 percent to close at $1.03 apiece as ...

Today, the California Rare Disease Access Coalition, Hemophilia Council of California, and Plasma Protein Therapeutics Association called for the swift passage of Assembly Bill 725, introduced by ...